Teva (TEVA) is up 19.2%, or $3.17 to $19.68. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on TEVA: Teva rises 19.2% Teva, Sanofi report RELIEVE UCCD Phase 2b study met primary endpoints Teva, Sanofi announce results from Phase 2b RELIEVE UCCD study Monte Rosa Therapeutics appoints Hughes to board of directors Teva call volume above normal and directionally bullish Questions or Comments about the article? Write to editor@tipranks.com